OIG Flags Subscription Referral Platforms for Anti-Kickback Risks

2 min readSources: National Law Review

The OIG warns subscription-based referral platforms may violate Anti-Kickback laws.

Why it matters: Legal and compliance teams must reassess these platforms to avoid regulatory scrutiny and enforcement actions tied to illegal referral practices.

  • OIG issued Advisory Opinion 26-15 on July 8, 2026, addressing a subscription-based referral platform.
  • Platforms offering subscriptions give providers competitive referral advantages over non-paying providers.
  • The arrangement doesn’t qualify for the referral services safe harbor under 42 C.F.R. § 1001.952(f).
  • OIG flagged risks including patient steering and incentives for unnecessary services linked to subscription fees.

On July 8, 2026, the U.S. Department of Health and Human Services Office of Inspector General (OIG) issued Advisory Opinion 26-15 addressing a subscription-based referral management software platform.

The platform allows home health agencies that pay subscription fees to receive and respond electronically to referral requests from hospitals. Non-subscribing agencies must rely on manual methods like fax, email, or telephone, putting them at a competitive disadvantage.

The OIG concluded this arrangement raises concerns under the federal Anti-Kickback Statute (AKS). It noted that "the arrangement effectively allows providers to improve their access to referrals by purchasing software subscriptions rather than competing on the quality of care they provide."

Crucially, the OIG determined the platform does not qualify for the referral services safe harbor under 42 C.F.R. § 1001.952(f). This safe harbor protects certain referral service arrangements from AKS liability, but the subscription model presented "more than a minimal risk of fraud and abuse," including patient steering and unfair competition.

Additional concerns include the potential for providers paying subscription fees to feel pressured to recoup those costs, which could result in overutilization or billing for medically unnecessary services reimbursable by federal health care programs.

Healthcare legal counsel and compliance officers should carefully review their use of these platforms in light of this advisory opinion to mitigate regulatory risks.

By the numbers:

  • July 8, 2026 — Date of OIG Advisory Opinion 26-15 addressing subscription platforms
  • 42 C.F.R. § 1001.952(f) — Referral services safe harbor cited as inapplicable